Learn About the Quiz
View Product Details
Available for Free on the App Store
Myriad Customer Service
Decrease costs while improving patient well-being
Learn More »
Accurate test results drive optimal treatments
If you are a payer or insurance provider, please contact us to receive more information.
EVP, Corporate Communications
VP, Investor Relations
800 4-MYRIAD (800 469-7423)
Myriad Genetics, Inc.
320 Wakara Way
Salt Lake City, UT 84108
At Myriad, our passion for patients drives everything we do – on the job and in the community.
Myriad is answering patients’ most pressing questions about disease.
Myriad has the deepest diagnostic pipeline across the disease spectrum.
At Myriad, we’re leveraging our unique expertise in sequencing and analysis to better understand human disease.
The Myriad myRisk Hereditary Cancer test is a 29-gene panel that identifies an elevated risk for eight hereditary cancers.
GeneSight meets a significant unmet clinical need and is the leading product for psychotropic drug selection.
EndoPredict helps doctors guide ER+, HER2- early-stage breast cancer patients toward the appropriate treatment decision.
Feb 15, 2019
Feb 13, 2019
When it comes to cancer, it is often said that “an ounce of cancer prevention is worth a ton of cancer
Myriad Genetics Second Quarter Fiscal 2019 Financial Results Conference Call
February 5, 2019
4:30 PM ET